CASI stock price could increase by 82%.
Jun 03, 2024, 10:02 PM
12.46%
What does CASI do
CASI Pharmaceuticals, headquartered in Beijing, focuses on developing and commercializing therapeutics, with a particular emphasis on hematology oncology and other medical needs worldwide. The company, which went public in 2021, markets products like EVOMELA in the U.S. and has several pipeline products and FDA-approved generics for the China market.
3 analysts think CASI stock price will increase by 81.60%. The current median analyst target is $6.12 compared to a current stock price of $3.37. The lowest analysts target is $6.06 and the highest analyst target is $6.30.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.